Jazz Pharmaceuticals (JAZZ) was upgraded to a 'Buy' recommendation by TheStreet.com's quantitative service today. Let's check out the price charts and technical indicators to see if they are in agreement.
More from Investing
Let's review the charts and indicators.
With the stock breaking out to a new high, a fresh look is in order.
Don't mistake a fear of missing out for a fundamental change in the industry.
An investor's job -- long or short -- is to take the opposite side of a position, and here's why we should take a critical look at this electric vehicle company.